Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.48B |
| 2 |
Apple
AAPL
|
+$610M |
| 3 |
Amazon
AMZN
|
+$538M |
| 4 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$379M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$337M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.14B |
| 2 |
VAR
Varian Medical Systems, Inc.
VAR
|
+$466M |
| 3 |
State Street Consumer Staples Select Sector SPDR ETF
XLP
|
+$420M |
| 4 |
Tesla
TSLA
|
+$251M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$242M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.39% |
| 2 | Financials | 7.95% |
| 3 | Communication Services | 5.87% |
| 4 | Consumer Discretionary | 5.85% |
| 5 | Healthcare | 5.58% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FRGI
3476
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $216K | ﹤0.01% |
16,033
-12,306
| -43% | -$168K |
|
3477
CALL
Consolidated Edison
ED
$39.8B
| $215K | ﹤0.01% |
3,000
| – | – |
|
3478
Ecovyst
ECVT
$1.32B
| $213K | ﹤0.01% |
13,837
-23,381
| -63% | -$369K |
|
|
GTT
3479
DELISTED
GTT Communications, Inc.
GTT
| $213K | ﹤0.01% |
87,702
+61,070
| +229% | +$119K |
|
3480
iRadimed
IRMD
$1.17B
| $212K | ﹤0.01% |
7,184
-4,117
| -36% | -$113K |
|
|
JMIA
3481
Jumia Technologies
JMIA
$754M
| $212K | ﹤0.01% |
7,000
-68,124
| -91% | -$2.06M |
|
3482
Banco Macro
BMA
$5.93B
| $211K | ﹤0.01% |
14,056
+7,891
| +128% | +$118K |
|
3483
Invesco DB Base Metals Fund
DBB
$312M
| $211K | ﹤0.01% |
10,411
+9,338
| +870% | +$188K |
|
3484
PAR Technology
PAR
$715M
| $211K | ﹤0.01% |
3,012
-12,969
| -81% | -$919K |
|
|
BCOV
3485
DELISTED
Brightcove, Inc.
BCOV
| $211K | ﹤0.01% |
14,697
-40,962
| -74% | -$658K |
|
3486
ALPS Clean Energy ETF
ACES
$120M
| $210K | ﹤0.01% |
+2,776
| New | +$198K |
|
3487
CB Financial Services
CBFV
$188M
| $210K | ﹤0.01% |
9,430
-2,994
| -24% | -$65.2K |
|
|
DOO
3488
Bombardier Recreational Products
DOO
$4.53B
| $210K | ﹤0.01% |
+2,679
| New | +$226K |
|
3489
Matrix Service
MTRX
$336M
| $210K | ﹤0.01% |
20,011
-15,599
| -44% | -$188K |
|
3490
PUT
Teva Pharmaceuticals
TEVA
$40.2B
| $210K | ﹤0.01% |
21,200
| – | – |
|
|
CDMO
3491
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $210K | ﹤0.01% |
8,224
-47,410
| -85% | -$1.01M |
|
|
VTNR
3492
DELISTED
Vertex Energy, Inc
VTNR
| $210K | ﹤0.01% |
+15,891
| New | +$65.9K |
|
3493
ProShares Ultra Dow30
DDM
$529M
| $209K | ﹤0.01% |
+5,808
| New | +$205K |
|
3494
Fomento Económico Mexicano
FMX
$42.8B
| $209K | ﹤0.01% |
+2,468
| New | +$202K |
|
3495
Invesco S&P SmallCap Low Volatility ETF
XSLV
$249M
| $208K | ﹤0.01% |
4,444
-511
| -10% | -$24K |
|
|
ADVM
3496
DELISTED
Adverum Biotechnologies
ADVM
| $207K | ﹤0.01% |
5,899
-12,026
| -67% | -$648K |
|
3497
Ceco Environmental
CECO
$3.99B
| $207K | ﹤0.01% |
28,957
-11,920
| -29% | -$92.2K |
|
|
OLP
3498
One Liberty Properties
OLP
$531M
| $206K | ﹤0.01% |
7,272
-21,712
| -75% | -$561K |
|
3499
Aclaris Therapeutics
ACRS
$772M
| $205K | ﹤0.01% |
11,767
+11,749
| +65,272% | +$267K |
|
3500
Atlanta Braves Holdings Series B
BATRK
$3.27B
| $205K | ﹤0.01% |
7,421
-22,938
| -76% | -$628K |
|
Similar funds
Barclays's Q2 2021 Portfolio in Review
As of Q2 2021, Barclays held 5,234 positions worth $212B, up 14% from $186B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Barclays deployed $11.1B of net new capital in Q2 2021, opening 558 new positions and adding to 1,559 existing holdings. Its largest new stake was Proofpoint, Inc.: 1,241,690 shares worth $216M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Communication Services.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.14B trimmed.
- Barclays's largest Q2 2021 buy was Proofpoint, Inc.: 1,241,690 shares worth $216M.
- Barclays added most to iShares US Real Estate ETF in Q2 2021, an estimated $1.48B increase.
- Barclays's biggest Q2 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.14B.
- Barclays fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $466M.
- Barclays's ten largest holdings make up 36% of its $212B portfolio in Q2 2021.
- Barclays opened 558 new positions and closed 327 in Q2 2021.
- Barclays's portfolio value rose 14% quarter-over-quarter to $212B.
Based on Barclays's 13F filing for Q2 2021, filed 13 Aug 2021.